Posters

      Cigarette smoke increases the adhesion of human monocytes to endothelial cells

      Lietz, M.; Berger, C.; H-Lammerich, H-P. Lammerich.; Steffen, Y.; Stolle, K.; Lebrun, S.; Schueller, J.; Wallerath, T.
      Conference date
      Jun 20, 2010
      Conference name
      European Atherosclerosis Society (EAS) 2010
      Link to more information
      Link to more information
      Topic
      Summary

      Cigarette smoking is a well-known risk factor for the development and progression of atherosclerosis. However, the mechanisms involved are not well understood. One early step in the initiation of atherosclerosis is the adhesion of monocytes to the vascular endothelium. The objective of this project was to investigate the impact of cigarette smoke (CS) on the adhesion properties of human monocytic cell line Mono Mac 6 (MM6) to human umbilical vein endothelial cells (HUVECs) in vitro. CS was bubbled through phosphate-buffered saline (PBS) and further diluted with cell culture medium to concentrations of 0.045 or 0.09 puffs/ml. HUVECs were exposed to CS preparations for 2 or 4 hours, and a gene array analysis (affymetrix) was performed. Up-regulation of three different adhesion molecules—vascular adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and endothelial selectin (E-selectin)—was confirmed by real-time polymerase chain reaction (PCR) and InCell-Western. To test whether the CS-induced up-regulation of adhesion molecules on the surface of the HUVECs was sufficient for the adhesion of MM6 cells, an in-vitro adhesion assay under static conditions was established. Additional adhesion experiments with blocking antibodies against VCAM1, ICAM1, and E-selectin showed E-selectin to have the strongest impact on the CS-induced adhesion of MM6 cells to HUVECs. Adhesion of peripheral blood mononuclear cells is reported to be higher in smokers than non-smokers; therefore, the adhesion properties of CS-exposed MM6 cells to untreated HUVECs were also investigated. No increased adhesion was detected. Conclusion: exposure to CS increases the adhesion of human monocytes to HUVECs in vitro. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.